2 FTSE 100 dividend stocks I like for 2020

Dividend stocks like GlaxoSmithKline plc (LON: GSK) and Aviva plc (LON:AV) are my top picks for 2020.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

2020 is likely to be a difficult year for the global economy. With growth slowing and some major economies on the verge of recession, the export-oriented FTSE 100 may see its earning power diminish next year. 

Even moderately lower corporate earnings could have a direct impact on dividends for many investors. The FTSE 100 currently offers a 4.4% dividend yield, which is both historically high and increasingly unsustainable.

Most of the top 10 dividend payers barely cover their annual dividends with profits or earnings. Some, like Vodafone, pay out more in dividends than they earn per share every year. 

If corporate profits are squeezed next year, many of the top payers may have to sustain dividends with their cash hoard or announce cuts. However, some companies have plenty of dividend coverage and are less exposed to the market cycle.

Here are two robust dividend stocks I would consider for next year.   

Insurance giant

Aviva’s (LSE: AV) share price has plummeted over the past few years, but now it seems like the valuation has been pushed too far. You can buy the shares for 6.9 times forward earnings, compared to 17 times forward earnings for the FTSE 100 as a whole.

Even as the share price plummeted over the past three years, the company’s underlying fundamentals improved. Profits have nearly doubled and dividend per share has jumped 44% since 2016. 

The confluence of a falling share price with rising earnings has made Aviva one of the most robust dividend stocks on the FTSE 100 at the moment. Not only is the attractive 7.7% dividend yield much higher than the index average, but the annual payout is also covered by earnings 1.9 times over. 

In other words, Aviva has plenty of earning power to sustain its dividend next year, and since the stock is already beaten down there’s not much downside risk left for shareholders to worry about, in my view. 

Pharmaceuticals 

Selling medicines and consumer staples is arguably a more recession-resistant business model than insurance. GlaxoSmithKline (LSE: GSK) stands out as a clear leader in this industry. Currently worth £86bn, this corporate giant is one of the most well-recognised British names in the world. 

British investors, however, are more familiar with the company as an attractive dividend payer. The share currently offers a 5.6% forward dividend yield. GSK’s dividend coverage ratio (annual earnings divided by annual dividends) is 1.45. The company also has £4.4bn in cash and cash equivalents on its books, which should cover the dividend for an entire year. 

The icing on the cake for investors is the fact that GSK offers potential for capital appreciation as well. The share price is up 22% over the past year and 30% over the past two years. That’s an annual growth rate of 14%.

Bottom line

GSK and Aviva both offer excellent dividend opportunities for income-seeking investors. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

VisheshR has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s how I’d aim for a ton of passive income from £20k in an ISA

To get the best passive income from an ISA, I think we need to balance risk with the potential rewards.…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

2 FTSE 100 stocks I’d buy as the blue-chip index hits record highs

This Fool takes a look at a pair of quality FTSE 100 stocks that appear well-positioned for future gains, despite…

Read more »

Satellite on planet background
Small-Cap Shares

Here’s why AIM stock Filtronic is up 44% today

The share price of AIM stock Filtronic has surged on the back of some big news in relation to its…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

At a record high, there can still be bargain FTSE 100 shares to buy!

The FTSE 100 closed at a new all-time high this week. Our writer explains why there might still be bargain…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

After profits plunge 28%, should investors consider buying Lloyds shares?

Lloyds has seen its shares wobble following the release of its latest results. But is this a chance for investors…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

Something’s changed in a good way for Reckitt in Q1, and the share price may be about to take off

With the Reckitt share price near 4,475p, is this a no-brainer stock? This long-time Fool takes a closer look at…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

This new boost in assets might just get the abrdn share price moving again

The abrdn share price has lost half its value in the past five years. But with investor confidence returning, are…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

As revenues rise 8%, is the Croda International share price set to bounce back?

The latest update from Croda International indicates that sales are starting to recover from the end of 2023, so is…

Read more »